Normal cellular counterparts of B cell chronic lymphocytic leukemia.

作者: AS Freedman , AW Boyd , FR Bieber , J Daley , K Rosen

DOI: 10.1182/BLOOD.V70.2.418.418

关键词: B-1 cellImmunologyCD20AntigenBiologyMolecular biologyReceptorCD5AntibodyImmunoglobulin ECD19

摘要: In an attempt to compare B cell chronic lymphocytic leukemia (B-CLL) with its normal cellular counterpart, the surface phenotype of 100 cases B-CLL was determined by using a panel monoclonal antibodies (MoAbs) directed against cell-restricted and -associated antigens. The majority cells expressed Ia, B4 (CD19), B1 (CD20), B2 (CD21), immunoglobulin (sIg), T1 (CD5) but lacked C3b (CD35) receptors. contrast, overwhelming small unstimulated B4, B1, B2, sIg, receptors detectable T1. Small numbers weakly sIg+ could be identified in peripheral blood tonsil that coexpressed Approximately 16% fetal splenocytes T1, weak Ia therefore closely resembled most cells. With phenotypic differences between cells, we examined vitro activated for expression activation Of 20 examined, virtually all B5, approximately 50% interleukin-2 (IL-2R) Blast-1. Normal were either anti-Ig or 12-0-tetradecanoylphorbol-beta-acetate (TPA) then coexpression antigens B5 IL-2R. Only TPA as well proliferated presence IL-2, whereas did not, although they identical 60-kilodalton proteins immunoprecipitation. These studies are consistent notion resembles several minor subpopulations including population directly through protein kinase C pathway.

参考文章(64)
Lee M. Nadler, Andrew W. Boyd, Edward Park, Kenneth C. Anderson, David Fisher, Bruce Slaughenhoupt, David A. Thorley-Lawson, Stuart F. Schlossman, The B Cell-Restricted Glycoprotein (B2) Is the Receptor for Epstein-Barr Virus Springer, New York, NY. pp. 509- 518 ,(1986) , 10.1007/978-1-4612-4848-4_44
L Hudson, R E Millard, J C Jensenius, A P Johnstone, Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes. Clinical and Experimental Immunology. ,vol. 47, pp. 697- 705 ,(1982)
P Stashenko, L M Nadler, S F Schlossman, R Hardy, Characterization of a human B lymphocyte-specific antigen. Journal of Immunology. ,vol. 125, pp. 1678- 1685 ,(1980)
D A Thorley-Lawson, A K Bhan, L M Nadler, R T Schooley, BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. Journal of Immunology. ,vol. 134, pp. 3007- 3012 ,(1985)
L A Herzenberg, F D Howard, J Wong, E B Stinson, C P Bieber, J A Ledbetter, A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation Journal of Immunology. ,vol. 126, pp. 2117- 2122 ,(1981)
R A Miller, J Gralow, The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). Journal of Immunology. ,vol. 133, pp. 3408- 3414 ,(1984)
L M Nadler, S F Schlossman, R F Todd, Antigens on human monocytes identified by monoclonal antibodies. Journal of Immunology. ,vol. 126, pp. 1435- 1442 ,(1981)
L M Nadler, S F Schlossman, J D Griffin, R Osathanondh, I J Rimm, T Umiel, P Rosenthal, Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. Journal of Immunology. ,vol. 131, pp. 232- 237 ,(1983)
F P Siegal, S Gupta, R A Good, Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clinical and Experimental Immunology. ,vol. 25, pp. 319- ,(1976)